Therapeutic agent for keratoconjunctiva diseases

Details Therapeutic agent for keratoconjunctiva diseases Therapeutic agent for keratoconjunctiva diseases

A - Human Necessities

61

K

A61K 31/232 (2006.01) A61K 9/08 (2006.01) A61K 31/22 (2006.01) A61P 27/04 (2006.01) A61P 27/14 (2006.01)

Patent

CA 2243824

The present invention provides a novel substance which promotes the production and secretion of mucin in ophthalmic tissues. The therapeutic agent for keratoconjunctiva diseases according to the present invention contains gefarnate as an active ingredient. This therapeutic agent for keratoconjunctiva diseases is applicable to dry eye, keratitis, conjunctivitis, corneal erosion, corneal ulcer, etc. The dosage form is preferably an ophthalmic solution. Concentration of gefarnate is, for example, 0.1-3% (w/v).

L'invention concerne une nouvelle substance qui facilite la production et la sécrétion de mucine dans les tissus oculaires, ainsi qu'un médicament contre les maladies de la cornée et de la conjonctive, qui contient du géfarnate comme principe actif et peut être utilisé dans la sécheresse oculaire, la kératite, la conjonctivite, le décollement de l'épithélium cornéen, l'ulcère cornéen, etc. Il se présente de préférence sous forme de gouttes ophtalmiques. Sa concentration en géfarnate peut aller de 0,1 à 3 % en poids/volume par exemple.

Affiliated with

Also associated with

Rating

Therapeutic agent for keratoconjunctiva diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for keratoconjunctiva diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for keratoconjunctiva diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2051349